References
- Agundez JA, Garcia-Martin E, Maestro ML, et al (2012). Relation of IL28B gene polymorphism with biochemical and histological features in hepatitis C virus-induced liverdisease. PLoS One, 7, 37998. https://doi.org/10.1371/journal.pone.0037998
- Asselah T, De Muynck S, Broet P, et al (2012). IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C. J Hepatol. 56, 527-32. https://doi.org/10.1016/j.jhep.2011.09.008
- Bruix J, Sherman M (2011). Management of hepatocellular carcinoma: an update AASLD, practice guidelines. Hepatol, 53, 1020-2. https://doi.org/10.1002/hep.24199
- Cheng P, Cheng Y, Su MX, et al (2012). Bicluster and pathway enrichment analysis of HCV-induced cirrhosis and hepatocellular carcinoma. Asian Pac J Cancer Prev, 13, 3741-5. https://doi.org/10.7314/APJCP.2012.13.8.3741
- El-Awady MK, Mostafa L, Tabll AA, et al (2012). Association of IL28B snp with progression of Egyptian HCV genotype 4 patients to end stage liver disease. Hepat Mon, 12, 271-7. https://doi.org/10.5812/hepatmon.6064
- Eurich D, Boas-Knoop S, Bahra M, et al (2012). Role of IL28B polymorphism in the development of hepatitis C virus-induced hepatocelular carcinoma, graft fibrosis, and posttransplant activiral therapy. Transpl, 93, 644-9.
- Fabris C, Falleti E, Cussigh A, et al (2011). IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC. J Hepatol. 54, 716-22 https://doi.org/10.1016/j.jhep.2010.07.019
- Falleti E, Bitetto D, Fabris C, et al (2011). Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype. J Clin Immunol, 31, 891-9. https://doi.org/10.1007/s10875-011-9547-1
- Marabita F, Aghemo A, De Nicola S, et al (2011). Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis c and known date of infection. Hepatol, 54, 1127-34. https://doi.org/10.1002/hep.24503
- Missiha SB, Ostrowski M, Heathcote EJ (2008). Disease progression in chronic hepatitis C: modifiable and non-modifiable factors. Gastroenterol, 134, 1699-714. https://doi.org/10.1053/j.gastro.2008.02.069
- Morgan TR (2011). Chemoprevention of hepatocellular carcinoma in chronic hepatitis C. Rec Results Cancer Res, 188, 85-99.
- Rauch A, Kutalik Z, Descombes P, et al (2010). Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterol, 138, 1338-45. https://doi.org/10.1053/j.gastro.2009.12.056
- Rehermann B (2009). Hepatitis C virus versus innate and adaptive immune responses: a tale of co evolution and coexistence. J Clin Invest, 119, 1745-54. https://doi.org/10.1172/JCI39133
- Sarrazin C, Susser S, Doehring A, et al (2011). Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients. J Hepatol, 54, 1099-106.
- Thomas DL, Thio CL, Martin MP, et al (2009). Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature, 461, 798-801 https://doi.org/10.1038/nature08463
- Thompson A, Clark PJ, Fellay J, et al (2010). IL28B genotype is not associated with advanced hepatic fibrosis in chronic hepatitis C patients enrolled in the IDEAL study. Hepatol, 52, 437
- Thompson AJ, Clark PJ, Singh A, et al (2012). Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients. J Hepatol, 56, 313-9. https://doi.org/10.1016/j.jhep.2011.04.021
- Zekri AR, Moharram RA, Mohamed WS, et al (2010). Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with repression of interferon regulatory factor-1. Eur J Gastroenterol Hepatol, 22, 450-6. https://doi.org/10.1097/MEG.0b013e3283329d00
- Zekri A, Hassan Z, Bahnassy A, et al (2012). Molecular prognostic profile of Egyptian HCC cases infected with hepatitis C virus. Asian Pac J Cancer Prev, 13, 5433-8. https://doi.org/10.7314/APJCP.2012.13.11.5433
- Zekri A, Nassar A, El-Rouby M, et al (2013). Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with increasing DNA promoter methylation. Asian Pac J Cancer Prev, 14, 6721- 6 https://doi.org/10.7314/APJCP.2013.14.11.6721
- Zhang X-L, Lu Y, Yang S, et al (2014). An updated metaanalysis between the Association of XRCC1 Arg399Gln Polymorphism and Hepatocellular Carcinoma Risk. Asian Pac J Cancer Prev, 15, 3273-8. https://doi.org/10.7314/APJCP.2014.15.7.3273
Cited by
- High Resolution Melting Curve Assay for Detecting rs12979860 IL28B Polymorphisms Involved in Response of Iranian Patients to Chronic Hepatitis C Treatment vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.1873
- Association between IL28B rs12979860 single nucleotide polymorphism and the frequency of colonic Treg in chronically HCV-infected patients vol.161, pp.11, 2016, https://doi.org/10.1007/s00705-016-3015-4
- Three Gene Signature for Predicting the Development of Hepatocellular Carcinoma in Chronically Infected Hepatitis C Virus Patients vol.36, pp.12, 2016, https://doi.org/10.1089/jir.2016.0042
- Host genetic factors associated with hepatocellular carcinoma in patients with hepatitis C virus infection: A systematic review vol.25, pp.5, 2018, https://doi.org/10.1111/jvh.12871